In addition, Abs targeting CD96 that failed to block CD96–CD155 interactions nonetheless enabled NK cells to suppress experimental and spontaneous metastases [23] suggesting the involvement of other CD96 ligands, e.g., CD111, in mediating NK anti-tumor activity. Here, CD96 is linked to neoplasm.